38 /100
MEDIUM RISK
Score updated May 30, 2026

VRDN — Viridian Therapeutics, Inc. Dilution Risk Tracker

Track VRDN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VRDN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
30
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📜 Warrant Exercise 15%
• Warrant overhang: 6.8% of shares outstanding
🔔 Track VRDN — Get forecast alerts →

💹 Market Data

Market Cap$1.95B
Shares Outstanding110.43M
Float103.02M
Cash$762.18M
Debt$53.35M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 14.7% shares (2025Q4 vs prior)
230 institutional holders · 108.68M shares
#1 FMR LLC 14.38M shares
#2 BlackRock, Inc. 6.43M shares
#3 VANGUARD GROUP INC 5.61M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.27M
Days to Cover3.1
% of Float13.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track VRDN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VRDN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for VRDN
📊 VRDN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VRDN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.